Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Jungmann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|December 4, 2023
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studiesFriederike Kanefendt, Christine Brase, Natalia Jungmann, et al.
Toxicology|May 21, 2025
Predicting in vitro assays related to liver function using probabilistic machine learningFlavio M Morelli, Marian Raschke, Natalia Jungmann, et al.
Journal of Medicinal Chemistry|February 13, 2024
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 InhibitorDaniel Meibom, Pierre Wasnaire, Kristin Beyer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|December 4, 2023
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studiesFriederike Kanefendt, Christine Brase, Natalia Jungmann, et al.
Toxicology|May 21, 2025
Predicting in vitro assays related to liver function using probabilistic machine learningFlavio M Morelli, Marian Raschke, Natalia Jungmann, et al.
Journal of Medicinal Chemistry|February 13, 2024
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 InhibitorDaniel Meibom, Pierre Wasnaire, Kristin Beyer, et al.
Pageof 1